New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cue Biopharma, Inc.
CUE
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

86M

Biotechnology

Next Earning date - 26 Mar 2025

86M

Biotechnology

Next Earning date - 26 Mar 2025

1.45USD

Shape0.04 ( 2.83%)
sun-fogPre-market 1.46$arrow-right-up0.01 (0.70%)
Market Closed (as of Feb 05, 17:39 EDT)
favorite-chart

Relative Strenght

14
favorite-chart

Volume Buzz

-82%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

44%

Quote Panel

Shape
Updated February 7, 2025
1W -4.26 % 1M -6.90 % 3M -21.51 % 1Y -42.55 %

Key Metrics

Shape
  • Market Cap

    85.52M


  • Shares Outstanding

    63.35M


  • Share in Float

    62.87M


  • Dividende

    0


  • Earning Date

    26 Mar 2025


  • Price Target

    1.35


  • Average Volume

    429770


  • Beta

    1.796


  • Range

    0.45-2.58


  • Industry

    Biotechnology


  • Website

    https://www.cuebiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CUE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

Shape213%

2025-Revenue

$0.52

Shape-207%

2025-EPS

$10M

Shape-38%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

4.00(196.30%)

Number of analyst

1

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Not converted

2022-11-20

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.37
vs -0.26

Q1.23

arrow
arrow

N/A

-0.29
vs -0.44

Q2.23

arrow
arrow

N/A

-0.29
vs -0.37

Q3.23

arrow
arrow

N/A

-0.24
vs -0.31

Q4.23

arrow
arrow

N/A

-0.37
vs -0.37

Q1.24

arrow
arrow

N/A

-0.25
vs -0.29

Q2.24

arrow
arrow

N/A

-0.20
vs -0.29

Q3.24

arrow
arrow

+100%

NA
vs -0.24

Q4.24

arrow
arrow

N/A

-0.09
vs -0.37

Q1.25

arrow
arrow

N/A

-0.16
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-98%

151.2K  vs 8.3M

Q1.23

arrow
arrow

-81%

187K  vs 1M

Q2.23

arrow
arrow

+5215%

1.4M  vs 26K

Q3.23

arrow
arrow

+2988%

2.1M  vs 68K

Q4.23

arrow
arrow

+1104%

1.8M  vs 151.2K

Q1.24

arrow
arrow

+818%

1.7M  vs 187K

Q2.24

arrow
arrow

+92%

2.7M  vs 1.4M

Q3.24

arrow
arrow

+59%

3.3M  vs 2.1M

Q4.24

arrow
arrow

-7%

1.7M  vs 1.8M

Q1.25

arrow
arrow

-26%

1.3M  vs 1.7M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-22%

-0.22
vs -0.21

Q1.23

arrow
arrow

-24%

-0.24
vs -0.22

Q2.23

arrow
arrow

-29%

-0.29
vs -0.24

Q3.23

arrow
arrow

-26%

-0.26
vs -0.29

Q4.23

arrow
arrow

-36%

-0.36
vs -0.26

Q1.24

arrow
arrow

-41%

-0.41
vs -0.36

Q2.24

arrow
arrow

-47%

-0.47
vs -0.41

Q3.24

arrow
arrow

-34%

-0.34
vs -0.47

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

63

63
vs 64

-2%

Q1.23

arrow
arrow

64

64
vs 63

2%

Q2.23

arrow
arrow

80

80
vs 64

25%

Q3.23

arrow
arrow

79

79
vs 80

-1%

Q4.23

arrow
arrow

85

85
vs 79

8%

Q1.24

arrow
arrow

79

79
vs 85

-7%

Q2.24

arrow
arrow

76

76
vs 79

-4%

Q3.24

arrow
arrow

51

51
vs 76

-33%

Earnings Growth

Latest News